| Literature DB >> 35419326 |
Ting You1, Yan-Rong Zhou2, Xiao-Chen Liu1, Lu-Quan Li1.
Abstract
Purpose: To identify risk factors associated with the development of acute respiratory distress syndrome (ARDS) in infants with early onset sepsis (EOS) and to describe the clinical features.Entities:
Keywords: acute respiratory distress syndrome; clinical characteristics; early onset sepsis; neonate; risk factors
Year: 2022 PMID: 35419326 PMCID: PMC8995893 DOI: 10.3389/fped.2022.847827
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
FIGURE 1Distribution of pathogens. Composition of major Gram-positive bacteria (A). Composition of major Gram-negative bacteria (B).
Demographic characteristics of infants enrolled in the present study.
| Variable | ARDS ( | Non-ARDS ( | Statistic |
|
| Gestational age, M (IQR), w | 33.86 (31.29–38.00) | 38.57 (36.43–39.86) | 5.390 | 0.000 |
| Birth weight, M (IQR), g | 2,000 (1,510–2,800) | 2,995 (2,519–3,400) | 5.268 | 0.000 |
| Apgar 1 min, M (IQR) | 8 (7–9) | 9 (8–10) | 2.744 | 0.006 |
| Apgar 5 min, M (IQR) | 9 (8–10) | 10 (9–10) | 4.014 | 0.000 |
| Male,% ( | 49.1 (27) | 60.5 (118) | 2.298 | 0.130 |
| Age of admission, M (IQR), h | 0.85 (0.08–4.67) | 4.97 (2.11–8.53) | 3.975 | 0.000 |
| Low birth weight,% ( | 61.8 (34) | 24.1 (47) | 27.862 | 0.000 |
| Prematurity,% ( | 70.9 (39) | 29.2 (57) | 31.504 | 0.000 |
| Meconium-stained amniotic fluid,% ( | 16.4 (9) | 19.0 (37) | 0.195 | 0.659 |
| PROM,% ( | 43.6 (24) | 17.9 (35) | 15.700 | 0.000 |
| Maternal hypertension,% ( | 5.5 (3) | 4.1 (8) | 0.004 | 0.953 |
| GDM,% ( | 9.1 (5) | 8.2 (16) | 0.000 | 1.000 |
| Antenatal steroid use,% ( | 30.9 (17) | 8.2 (16) | 19.300 | 0.000 |
| Cesarean section, | 50.9 (28) | 46.7 (91) | 0.310 | 0.578 |
| Twins, | 34.5 (19) | 17.9 (35) | 0.978 | 0.008 |
| ICP, | 3.6 (2) | 1.5 (3) | 0.190 | 0.663 |
| Total volume within 24 h after birth, (± SD), ml/kg | 84.41 ± 15.18 | 81.39 ± 17.23 | 0.914 | 0.473 |
PROM: premature rupture of membranes >18 h; GDM: gestational diabetes mellitus; ICP: intrahepatic cholestasis of pregnancy; M: median; IQR: interquartile range.
Comparison of laboratory results between the two groups of infants.
| Variable | ARDS ( | Non-ARDS ( | Statistic |
|
| Albumin, M (IQR), g/L | 27.35 (24.70–32.63) | 32.60 (28.30–36.60) | 3.998 | 0.000 |
| WBC < 5 or > 30 (× 109/L),% (n) | 30.8 (16) | 21.2 (41) | 2.082 | 0.149 |
| Hemoglobin (± SD), g/L | 144.1 ± 30.51 | 153.23 ± 36.08 | 1.653 | 0.100 |
| I/T > 0.16,% ( | 13.7 (7) | 11.9 (20) | 0.011 | 0.918 |
| Platelet count < 100 × 109/L,% ( | 21.2 (11) | 20.7 (40) | 0.005 | 0.946 |
| CRP > 10 mg/L,% ( | 42.3 (22) | 43.6 (79) | 0.029 | 0.864 |
| Gram-negative bacteria,% ( | 69.1 (38) | 62.1 (121) | 0.918 | 0.388 |
WBC: white blood cell count; I/T: immature/total neutrophil; CRP: C-reactive protein; M: median; IQR: interquartile range.
FIGURE 2Relationship between birth weight, serum albumin level, and the incidence of acute respiratory distress syndrome (ARDS). With the decrease of birth weight, the incidence of ARDS increased gradually (A). With the decrease of plasma albumin level, the incidence of ARDS increased gradually (B).
Comparison of neonatal complications between the two groups of infants.
| Variable | ARDS ( | Non-ARDS ( | Statistic |
|
| IVH,% ( | 40.0 (22) | 15.4 (30) | 15.779 | 0.000 |
| PPNH,% ( | 30.9 (17) | 5.6 (11) | 27.540 | 0.000 |
| BPD,% ( | 7.3 (4) | 0.5 (1) | 6.850 | 0.009 |
| Septic shock,% ( | 16.4 (9) | 3.1 (61) | 11.176 | 0.001 |
| Pulmonary hemorrhage,% ( | 21.8 (12) | 1.5 (3) | 27.790 | 0.000 |
| NEC,% ( | 7.3 (4) | 11.8 (23) | 0.921 | 0.340 |
| Hypoglycemia,% ( | 21.8 (12) | 7.7 (15) | 8.886 | 0.003 |
| Renal insufficiency,% ( | 40.0 (22) | 12.3 (24) | 21.911 | 0.000 |
| Coagulation dysfunction,% ( | 58.1 (32) | 29.7 (58) | 15.058 | 0.000 |
| Heart failure,% ( | 3.6 (2) | 0.0 (0) | – | 0.048 |
IVH: intraventricular hemorrhage; PPHN: persistent pulmonary hypertension; BPD: bronchopulmonary dysplasia; NEC: necrotizing enterocolitis.
Rates of Gram-negative bacteria susceptibility to different antibiotics [% (n)].
| Variable | Total ( | ARDS ( | Non-ARDS ( | Statistics |
|
|
| |||||
| Piperacillin | 21.8 (26) | 15.4 (4) | 23.7 (22) | 0.814 | 0.367 |
|
| |||||
| Ampicillin + Sulbactam | 45.2 (66) | 48.6 (17) | 44.1 (49) | 0.211 | 0.646 |
| Piperacillin + Tazobactam | 73.5 (108) | 72.2 (26) | 73.9 (82) | 0.038 | 0.845 |
|
| |||||
| Cefazolin | 31.1 (47) | 33.3 (12) | 30.4 (35) | 0.107 | 0.743 |
| Ceftazidime | 59.7 (92) | 55.6 (20) | 61.0 (72) | 0.342 | 0.559 |
| Cefotaxime | 39.9 (61) | 30.6 (11) | 42.7 (50) | 1.703 | 0.192 |
|
| |||||
| Imipenem | 91.9 (143) | 91.7 (33) | 90.9 (110) | 0.00 | 1.000 |
|
| |||||
| Levofloxacin | 87.8 (130) | 75.0 (27) | 92.0 (103) | 5.837 | 0.016 |
| Ciprofloxacin | 86.1 (130) | 77.8 (28) | 88.7 (102) | 2.730 | 0.099 |
|
| |||||
| Amikacin | 96.5 (138) | 94.3 (33) | 97.2 (105) | 0.676 | 0.770 |
| Gentamicin | 76.8 (116) | 63.9 (23) | 80.9 (93) | 4.440 | 0.035 |
|
| |||||
| ESBL (+),% ( | 53.3 (72) | 66.7 (22) | 49.0 (50) | 3.120 | 0.077 |
Partial strains were not tested for sensitivity to this drug; the denominator inside parentheses comprises the actual bacterial strains tested for sensitivity to this drug. ESBL: extended-spectrum β-lactamases.
Rates of gram-positive bacteria susceptibility to different antibiotics [% (n)].
| Variable | Total ( | ARDS ( | Non-ARDS ( | Statistics |
|
|
| |||||
| Ampicillin | 36.2 (17) | 62.5 (5) | 30.8 (39) | 1.684 | 0.194 |
|
| |||||
| Teicoplanin | 100.0 (74) | 100.0 (12) | 100.0 (62) | – | – |
| Vancomycin | 100.0 (88) | 100.0 (14) | 100.0 (71) | – | – |
|
| |||||
| Azithromycin | 31.6 (12) | 33.3 (2) | 31.3 (10) | 0.000 | 1.000 |
| Erythromycin | 29.9 (26) | 33.3 (5) | 29.2 (21) | 0.000 | 0.991 |
|
| |||||
| Levofloxacin | 61.8 (40) | 64.3 (9) | 68.9 (31) | 0.000 | 1.000 |
| Ciprofloxacin | 61.8 (47) | 61.5 (8) | 61.9 (39) | 0.000 | 1.000 |
|
| |||||
| Amikacin | 58.8 (20) | 62.5 (5) | 57.7 (15) | 0.000 | 1.000 |
| Gentamicin | 70.5 (55) | 62.2 (9) | 70.8 (46) | 0.000 | 1.000 |
|
| |||||
| Linezolid | 100.0 (84) | 100.0 (14) | 100.0 (76) | – | – |
|
| |||||
| Tigecycline | 100.0 (47) | 100.0 (9) | 100.0 (38) | – | – |
| Amoxicillin-clavulanic acid | 25.6 (20) | 28.6 (4) | 25.0 (16) | 0.000 | 1.000 |
| Rifampicin | 86.6 (58) | 88.9 (8) | 86.2 (50) | 0.000 | 1.000 |
Partial strains were not tested for sensitivity to this drug; the denominator inside parentheses comprises the actual bacterial strains tested for sensitivity to this drug.